Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Systematic Review
  • Published:

Epidemiology and Population Health

Effectiveness and safety of intermittent fasting on blood pressure in adults with overweight or obesity: a systematic review

Abstract

Background

Previous intermittent fasting (IF) studies have reported inconsistent findings regarding its antihypertensive effects and safety.

Objective

This study aimed to assess the effects and safety of IF on blood pressure (BP), anthropometrics, and cardiometabolic risk markers in individuals with overweight or obesity compared to a no-intervention control group.

Methods

Relevant studies were retrieved from multiple databases, including CNKI, Wanfang, VIP, SinoMed, PubMed, Embase, the Cochrane Library, and Web of Science, up to April 30, 2024. A meta-analysis was performed using Stata version 18.0 and RevMan 5.4, calculating mean differences (MD) or risk ratios (RR) with 95% confidence intervals (CI) via the Knapp-Hartung modified random-effects model. Publication bias was evaluated using a contour-enhanced funnel plot and Egger’s test.

Results

Fifteen studies (n = 929) were included. IF significantly reduced systolic blood pressure (SBP) (MD = –4.43 mmHg, 95% CI: –5.83 to –3.03, p < 0.001) and diastolic blood pressure (DBP) (MD = –2.00 mmHg, 95% CI: –3.23 to –0.78, p < 0.001) compared to control. IF also improved anthropometric measures, Homeostatic Model Assessment of Insulin Resistance (HOMA-IR), and Triglycerides (TG). Seven studies reported minor adverse effects. Although the IF group showed a higher risk of vomiting (RR = 1.11, 95% CI: 1.04–1.19, p = 0.01) and irritability (RR = 1.22, 95% CI: 1.13–1.31, p < 0.001) compared to the control group, these reactions were predominantly observed during the initial phase of the intervention and were self-resolving.

Conclusions

IF significantly lowered SBP and DBP in individuals with overweight or obesity, particularly in high-risk subgroups (obesity, age ≥45 years, and prehypertension/hypertension), with a favorable safety profile. Due to heterogeneity, future trials should standardize IF regimens and target these subgroups to confirm generalizability.

Clinical trial registration

The review protocol has been registered on PROSPERO (CRD42024540777).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2: Forest plots of IF vs. no intervention based on SBP changes.
Fig. 3: Forest plots of IF vs no intervention based on DBP changes.

Similar content being viewed by others

Data availability

The original contributions presented in the study are included in the article; further inquiries can be directed to the corresponding authors.

References

  1. WHO. Obesity and overweight [EB]. (2024-03-01)[2025-04-08]. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

  2. WHO. Global report on hypertension: the race against a silent killer [EB]. (2023-09-19)[2025-04-08]. https://www.who.int/publications/i/item/9789240081062.

  3. Shariq OA, McKenzie TJ. Obesity-related hypertension: a review of pathophysiology, management, and the role of metabolic surgery. Gland Surg. 2020;9:80–93.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Cherfan M, Vallée A, Kab S, Salameh P, Goldberg M, Zins M, et al. Unhealthy behaviors and risk of uncontrolled hypertension among treated individuals-The CONSTANCES population-based study. Sci Rep. 2020;10:1925.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol. 2020;16:223–37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Jiang YH, Zhang P, Tao Y, Liu Y, Cao G, Zhou L, et al. Banxia Baizhu Tianma decoction attenuates obesity-related hypertension. J Ethnopharmacol. 2021;266:113453.

    Article  CAS  PubMed  Google Scholar 

  7. Ryu S, Frith E, Pedisic Z, Kang M, Loprinzi PD. Secular trends in the association between obesity and hypertension among adults in the United States, 1999-2014. Eur J Intern Med. 2019;62:37–42.

    Article  PubMed  Google Scholar 

  8. Charchar FJ, Prestes PR, Mills C, Ching SM, Neupane D, Marques FZ, et al. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. J Hypertens. 2024;42:23–49.

    Article  CAS  PubMed  Google Scholar 

  9. Bakris G, Ali W, Parati G. ACC/AHA versus ESC/ESH on hypertension guidelines: JACC guideline comparison. J Am Coll Cardiol. 2019;73:3018–26.

    Article  PubMed  Google Scholar 

  10. Patikorn C, Roubal K, Veettil SK, Chandran V, Pham T, Lee YY, et al. Intermittent fasting and obesity-related health outcomes. JAMA Netw Open. 2021;4:e2139558.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Al-Jafar R, Zografou Themeli M, Zaman S, Akbar S, Lhoste V, Khamliche A, et al. Effect of religious fasting in Ramadan on blood pressure: results from LORANS (London Ramadan Study) and a meta‐analysis. J Am Heart Assoc. 2021;10:e021560.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Liu L, Chen W, Wu D, Hu F. Metabolic efficacy of time-restricted eating in adults: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab. 2022;107:3428–41.

    Article  PubMed  Google Scholar 

  13. Silverii GA, Cresci B, Benvenuti F, Santagiuliana F, Rotella F, Mannucci E. Effectiveness of intermittent fasting for weight loss in individuals with obesity: A meta-analysis of randomized controlled trials. Nutr Metab Cardiovas. 2023;33:1481–9.

    Article  Google Scholar 

  14. Harris L, Hamilton S, Azevedo LB, Olajide J, De Brún C, Waller G, et al. Intermittent fasting interventions for treatment of overweight and obesity in adults: a systematic review and meta-analysis. JBI Database Syst Rev Implement Rep. 2018;16:507–47.

    Article  Google Scholar 

  15. Chen W, Liu X, Bao L, Yang P, Zhou H. Health effects of the time-restricted eating in adults with obesity: a systematic review and meta-analysis. Front Nutr. 2023;10:1079250.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Lin YJ, Wang YT, Chan LC, Chu NF. Effect of time-restricted feeding on body composition and cardio-metabolic risk in middle-aged women in Taiwan. Nutrition 2022;93:111504.

    Article  PubMed  Google Scholar 

  17. Abstracts from the American Heart Association Epidemiology and Prevention|Lifestyle and Cardiometabolic Health Scientific Sessions 2024. AHA; 2024;Abstract P192.

  18. Hutton B, Salanti G, Caldwell DM, Chaimani A, Schmid CH, Cameron C, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med. 2015;162:777–84.

    Article  PubMed  Google Scholar 

  19. Trepanowski JF, Kroeger CM, Barnosky A, Klempel MC, Bhutani S, Hoddy KK, et al. Effect of alternate-day fasting on weight loss, weight maintenance, and cardioprotection among metabolically healthy obese adults: A randomized clinical trial. JAMA Intern Med. 2017;177:930–8.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Cui Y, Cai T, Zhou Z, Mu Y, Lu Y, Gao Z, et al. Health effects of alternate-day fasting in adults: a systematic review and meta-analysis. Front Nutr. 2020;7:586036.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Whiting P, Savović J, Higgins JPT, Caldwell DM, Reeves BC, Shea B, et al. ROBIS: a new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225–34.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Higgins JPT, Li T, Deeks JJ. Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA editors. Cochrane Handbook for Systematic Reviews of Interventions version 6. Cochrane, 2023.

  23. Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol. 1992;45:769–73.

    Article  CAS  PubMed  Google Scholar 

  24. Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines. Part 1 of 3. An overview of the GRADE approach and grading quality of evidence about interventions. Allergy. 2009;64:669–77.

  25. Liu JY, Ni DM. Analysis of the intervention of “52 intermittent fasting” dietary pattern in obese individuals. Chin J Diab Mellit. 2023;15:852–6.

    Google Scholar 

  26. Sun JC. The effect of intermittent energy restriction in young and middle-aged overweight/obese patients with hypertension. Zhejiang University of Traditional Chinese Medicine. 2022.

  27. Chen HJ, Gao J. The effect of nutritional therapy based on fasting diet pattern in overweight and obese populations. China Mod Dr. 2020;58:127–9.

    Article  Google Scholar 

  28. Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Varady KA. Alternate day fasting and endurance exercise combine to reduce body weight and favorably alter plasma lipids in obese humans. Obesity 2013;21:1370–9.

    Article  CAS  PubMed  Google Scholar 

  29. Hirsh SP, Pons M, Joyal SV, Swick AG. Avoiding holiday seasonal weight gain with nutrient-supported intermittent energy restriction: a pilot study. J Nutr Sci. 2019;8:e11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Gabel K, Hoddy KK, Haggerty N, Song J, Kroeger CM, Trepanowski JF, et al. Effects of 8-hour time restricted feeding on body weight and metabolic disease risk factors in obese adults: A pilot study. Nutr Healthy Aging. 2018;4:345–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Oh M, Kim S, An KY, Min J, Yang HI, Lee J, et al. Effects of alternate day calorie restriction and exercise on cardio-metabolic risk factors in overweight and obese adults: an exploratory randomized controlled study. BMC Public Health. 2018;18:1124.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Cienfuegos S, Gabel K, Kalam F, Ezpeleta M, Wiseman E, Pavlou V, et al. Effects of four-hour and six-hour time-restricted feeding on weight and cardiometabolic health: a randomized controlled trial in adults with obesity. Cell Metab. 2020;32:366–378.e3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Lowe DA, Wu N, Rohdin-Bibby L, Moore AH, Kelly N, Liu YE, et al. Effects of time-restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity: the TREAT randomized clinical trial. JAMA Intern Med. 2020;180:1491–9.

    Article  PubMed  Google Scholar 

  34. Zhang LM, Liu Z, Wang JQ, Li RQ, Ren JY, Gao X, et al. Randomized controlled trial for time-restricted eating in overweight and obese young adults. iScience. 2022;25:104870.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Kotarsky CJ, Johnson NR, Mahoney SJ, Mitchell SL, Schimek RL, Stastny SN, et al. Time-restricted eating and concurrent exercise training reduces fat mass and increases lean mass in overweight and obese adults. Physiol Rep. 2021;9:e14868.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Haganes KL, Silva CP, Eyjólfsdóttir SK, Steen S, Grindberg M, Lydersen S, et al. Time-restricted eating and exercise training improve HbA1c and body composition in women with overweight/obesity: a randomized controlled trial. Cell Metab. 2022;34:1457–1471.e4.

    Article  CAS  PubMed  Google Scholar 

  37. Chow LS, Manoogian ENC, Alvear A, Fleischer JG, Thor H, Dietsche K, et al. Time-restricted eating effects on body composition and metabolic measures in humans who are overweight: a feasibility study. Obesity 2020;28:860–9.

    Article  CAS  PubMed  Google Scholar 

  38. Lin S, Cienfuegos S, Ezpeleta M, Gabel K, Pavlou V, Mulas A, et al. Time-restricted eating without calorie counting for weight loss in a racially diverse population: a randomized controlled trial. Ann Intern Med. 2023;176:885–95.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Phillips NE, Mareschal J, Schwab N, Manoogian E, Borloz S, Ostinelli G, et al. The effects of time-restricted eating versus standard dietary advice on weight, metabolic health and the consumption of processed food: a pragmatic randomised controlled trial in community-based adults. Nutrients 2021;13:1042.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Papageorgiou M, Biver E, Mareschal J, Phillips NE, Hemmer A, Biolley E, et al. The effects of time-restricted eating and weight loss on bone metabolism and health: a 6-month randomized controlled trial. OBESITY 2023;31:85–95.

    Article  CAS  PubMed  Google Scholar 

  41. Chen SY. Effects of Time-restricted Feeding and walking Exercise on Body Composition, Bone Mineral Density and Blood Lipids of Hidden Obesity female college Students. Henan University of Traditional Chinese Medicine. 2024.

  42. Teng NIMF, Shahar S, Rajab NF, Manaf ZA, Johari MH, Ngah WZW. Improvement of metabolic parameters in healthy older adult men following a fasting calorie restriction intervention. Aging Male. 2013;16:177–83.

    Article  CAS  PubMed  Google Scholar 

  43. Kord-Varkaneh H, Nazary-Vannani A, Mokhtari Z, Salehi-sahlabadi A, Rahmani J, Clark CCT, et al. The influence of fasting and energy restricting diets on blood pressure in humans: a systematic review and meta-analysis. High Blood Press Cardiovasc Prev. 2020;27:271–80.

    Article  PubMed  Google Scholar 

  44. Jamshed H, Steger FL, Bryan DR, Richman JS, Warriner AH, Hanick CJ, et al. Effectiveness of early time-restricted eating for weight loss, fat loss, and cardiometabolic health in adults with obesity: a randomized clinical trial. JAMA Intern Med. 2022;182:953–62.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Conley M, Le Fevre L, Haywood C, Proietto J. Is two days of intermittent energy restriction per week a feasible weight loss approach in obese males? A randomised pilot study. Nutr Diet. 2018;75:65–72.

    Article  PubMed  Google Scholar 

  46. Sun ML, Yao W, Wang XY, Gao S, Varady KA, Forslund SK, et al. Intermittent fasting and health outcomes: an umbrella review of systematic reviews and meta-analyses of randomised controlled trials. eClinicalMedicine. 2024;70:102519.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Wilson PW, D’Agostino RB, Sullivan L, Parise H, Kannel WB. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med. 2002;162:1867–72.

    Article  PubMed  Google Scholar 

  48. Yoo JK, Fu Q. Impact of sex and age on metabolism, sympathetic activity, and hypertension. FASEB J 2020;34:11337–46.

    Article  CAS  PubMed  Google Scholar 

  49. Mattson MP, Moehl K, Ghena N, Schmaedick M, Cheng A. Intermittent metabolic switching, neuroplasticity and brain health. Nat Rev Neurosci. 2018;19:63–80.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Yao K, Su H, Cui K, Gao Y, Xu D, Wang Q, et al. Effectiveness of an intermittent fasting diet versus regular diet on fat loss in overweight and obese middle-aged and elderly people without metabolic disease: a systematic review and meta-analysis of randomized controlled trials. J Nutr Health Aging. 2024;28:100165.

    Article  CAS  PubMed  Google Scholar 

  51. Anton S, Ezzati A, Witt D, McLaren C, Vial P. The effects of intermittent fasting regimens in middle-age and older adults: Current state of evidence. Exp Gerontol. 2021;156:111617.

    Article  PubMed  Google Scholar 

  52. Liang X, Chen J, An X, Ren Y, Liu Q, Huang L, et al. The optimal time restricted eating interventions for blood pressure, weight, fat mass, glucose, and lipids: A meta-analyses and systematic review. Trends Cardiovasc Med. 2023;34:389–401.

    Article  PubMed  Google Scholar 

  53. Svendsen M, Forslund HB. Meal patterns, including intermittent fasting – a scoping review for Nordic Nutrition Recommendations 2023. Food Nutr Res. 2024;68:1–23.

    Article  Google Scholar 

  54. Roman YM, Dominguez MC, Easow TM, Pasupuleti V, White CM, Hernandez AV. Effects of intermittent versus continuous dieting on weight and body composition in obese and overweight people: a systematic review and meta-analysis of randomized controlled trials. Int J Obes. 2019;43:2017–27.

    Article  Google Scholar 

  55. Ezpeleta M, Cienfuegos S, Lin S, Pavlou V, Gabel K, Tussing-Humphreys L, et al. Time-restricted eating: watching the clock to treat obesity. Cell Metab. 2024;36:301–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Varady KA, Lin S, Oddo VM, Cienfuegos S. Debunking the myths of intermittent fasting. Nat Rev Endocrinol. 2024;20:503–4.

    Article  PubMed  Google Scholar 

  57. Conde-Pipó J, Mora-Fernandez A, Martinez-Bebia M, Gimenez-Blasi N, Lopez-Moro A, Latorre JA, et al. Intermittent fasting: does it affect sports performance? a systematic review. Nutrients 2024;16:168.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Xie Y, Yu C, Zhou W, Zhu L, Wang T, Bao H, et al. Relationship between normal weight central obesity and arterial stiffness in Chinese adults with hypertension. Nutr, Metab Cardiovasc Dis. 2024;34:343–52.

    Article  PubMed  Google Scholar 

  59. Schwingshackl L, Zähringer J, Nitschke K, Torbahn G, Lohner S, Kühn T, et al. Impact of intermittent energy restriction on anthropometric outcomes and intermediate disease markers in patients with overweight and obesity: systematic review and meta-analyses. Crit Rev Food Sci Nutr. 2021;61:1293–304.

    Article  CAS  PubMed  Google Scholar 

  60. Tutor AW, Lavie CJ, Kachur S, Milani RV, Ventura HO. Updates on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2023;78:2–10.

    Article  PubMed  Google Scholar 

  61. Ren H, Guo Y, Wang D, Kang X, Yuan G. Association of normal-weight central obesity with hypertension: a cross-sectional study from the China health and nutrition survey. BMC Cardiovasc Disord. 2023;23:120.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Gupta RD, Parray AA, Kothadia RJ, Pulock OS, Pinky SD, Haider SS, et al. The association between body mass index and abdominal obesity with hypertension among South Asian population: findings from nationally representative surveys. Clin Hypertens. 2024;30:3.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Mohseni P, Khalili D, Djalalinia S, Mohseni H, Farzadfar F, Shafiee A, et al. The synergistic effect of obesity and dyslipidemia on hypertension: results from the STEPS survey. Diabetol Metab Syndr. 2024;16:81.

    Article  PubMed  PubMed Central  Google Scholar 

  64. de Koning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J. 2007;28:850–6.

    Article  PubMed  Google Scholar 

  65. Yang F, Liu C, Liu X, Pan X, Li X, Tian L, et al. Effect of epidemic intermittent fasting on cardiometabolic risk factors: a systematic review and meta-analysis of randomized controlled trials. Front Nutr. 2021;8:669325.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Zhang Q, Zhang C, Wang H, Ma Z, Liu D, Guan X, et al. Intermittent fasting versus continuous calorie restriction: which is better for weight loss? Nutrients 2022;14:1781.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Varady KA, Cienfuegos S, Ezpeleta M, Gabel K. Cardiometabolic benefits of intermittent fasting. Annu Rev Nutr. 2021;41:333–61.

    Article  CAS  PubMed  Google Scholar 

  68. Jayawardena R, Sooriyaarachchi P, Misra A. Abdominal obesity and metabolic syndrome in South Asians: prevention and management. Expert Rev Endocrinol Metab. 2021;16:339–49.

    Article  CAS  PubMed  Google Scholar 

  69. Zhong F, Zhu T, Jin X, Chen X, Wu R, Li S, et al. Adverse events profile associated with intermittent fasting in adults with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials. Nutr J. 2024;23:72.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Li DX. Brief discussion on Bigu method in Taoist medicine. China J Tradit Chin Med Pharm. 2012;27:1230–2.

    Google Scholar 

  71. Voroshilov AP, Volinsky AA, Wang Z, Marchenko EV. Modified qigong breathing exercise for reducing the sense of hunger on an empty stomach. J Evid Based Complementary Alter Med. 2017;22:687–95.

    Article  Google Scholar 

  72. Guo JH, Liao JX, Luo RQ, Yan XW, Li BY. Effect of traditional Chinese medicine “Fuqi Bigu” technique (TCM-guided fasting with Qi-regulation) on blood pressure. China J Tradit Chin Med Pharm. 2020;35:4732–4.

    Google Scholar 

  73. Venturini C, Mancinelli L, Matacchione G, Olivieri F, Antonicelli R. The cardioprotective effects of nutritional ketosis: mechanisms and clinical implications. Nutrients 2024;16:4204.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Puchalska P, Crawford PA. Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Cell Metab. 2017;25:262–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This research was supported by the Haidian District Health Development Research and Cultivation Program (No: HP2024-52-504002) and Xiyuan Hospital CACMS Enhancement Fund (NO. XYZX0101-14). The funders had no role in study design, data collection, data analysis, data interpretation, or writing of the manuscript.

Author information

Authors and Affiliations

Authors

Contributions

YXG, study design, data interpretation, and writing – original draft. LJL, literature search, screening, extraction, and quality assessment. LYC, literature search, screening, extraction, and quality assessment. YJW, literature search, screening, literature extraction, and quality assessment. FFZ, study design, methodology, and writing – review & editing; YRJ, study design, funding acquisition, supervision, and writing – review & editing. All authors contributed to the article and approved the final manuscript.

Corresponding authors

Correspondence to Fangfang Zhao or Yuerong Jiang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Guo, Y., Lu, L., Chen, L. et al. Effectiveness and safety of intermittent fasting on blood pressure in adults with overweight or obesity: a systematic review. Int J Obes 49, 1240–1251 (2025). https://doi.org/10.1038/s41366-025-01823-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41366-025-01823-4

Search

Quick links